← Back to Search

Behavioral Intervention

PT with ACBT and Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD)

Phase 3
Waitlist Available
Led By William E Pelham, PHD
Research Sponsored by Florida International University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 6 months after randomization to treatment
Awards & highlights

Study Summary

This trial will test the efficacy of a brief intervention for substance use in adolescents with ADHD.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 6 months after randomization to treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 6 months after randomization to treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Evidence of Illicit Substances in Urine Screen
Number of Participants With Past 90-day Alcohol Use
Secondary outcome measures
Mean Youth Self-Report of Disruptive Behaviors
Mean Youth Self-Report of Functional Impairment
Mean Youth Self-Report of Likelihood of Future Substance Use
+1 more

Trial Design

3Treatment groups
Active Control
Group I: PT with ACBT and MethylphenidateActive Control3 Interventions
All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT and Methylphenidate arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (ACBT). Adolescents will also receive methylphenidate.
Group II: PT with ACBTActive Control2 Interventions
All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. For participants randomized to the PT with ACBT arm, parents will participate in behavioral parent training (PT) and adolescents will participate in cognitive behavioral therapy to reduce substance use (CBT).
Group III: Continued Monitoring and AssessmentActive Control1 Intervention
All participants will receive 5 sessions of BEI. Non-responders will then be randomized to one of three conditions. Participants randomized to the continued monitoring and assessment arm will receive no additional intervention. Primary and secondary outcomes will be monitored.

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor
100 Previous Clinical Trials
17,397 Total Patients Enrolled
16 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
2,163 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
William E Pelham, PHDPrincipal InvestigatorFlorida International University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Intervention for Teens With ADHD and Substance Use
2015. "Intervention for Teens With ADHD and Substance Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02502799.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top